We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8766:TSETokio Marine Holdings, Inc. Analysis

Data as of 2026-05-21 - not real-time

¥7,830.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Tokio Marine Holdings is trading at ¥7,830, comfortably above its 20‑day SMA of ¥7,327 and 50‑day SMA of ¥6,995, indicating a solid bullish price trend. The RSI sits at 66.9, just below overbought levels, while the MACD histogram remains positive, reinforcing short‑term momentum. Valuation metrics are attractive: a trailing P/E of 15.2 is below the industry average of 16.7, and the dividend yield of 3.13% offers a compelling income component with a modest 42% payout ratio. Revenue growth of 21.8% YoY and a robust ROE of 20.6% underscore strong earnings momentum, while a low beta (~0.12) suggests limited market‑wide volatility despite a 30‑day price volatility of ~27.9%.
Analyst consensus has been nudged upward, with the mean price target now at ¥8,066, reflecting confidence in the company’s growth trajectory and dividend sustainability. The combination of bullish technicals, undervalued fundamentals, and a stable dividend makes Tokio Marine a compelling buy across horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMA20/50, positive MACD)
  • Attractive dividend yield with sustainable payout
  • Undervalued P/E relative to industry peers

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth (21.8% YoY) and high ROE (20.6%)
  • Improving analyst price targets (mean ¥8,066)
  • Solid balance sheet with ample cash and manageable debt

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Resilient insurance franchise with diversified product mix
  • Consistent dividend policy supporting income investors
  • Low market beta and stable liquidity for a large‑cap Japanese insurer

Key Metrics & Analysis

Financial Health

Revenue Growth21.80%
Profit Margin12.56%
P/E Ratio15.2
ROE20.66%
ROA2.94%
Debt/Equity4.22
P/B Ratio2.8
Industry P/E16.7

Technical Analysis

TrendBullish
RSI66.9
Support¥6,934.00
Resistance¥8,038.00
MA 20¥7,327.45
MA 50¥6,995.36
MA 200¥6,292.68
MACDBullish
VolumeStable
Fear & Greed Index90.29

Valuation

Target Price¥8,066.00
Upside/Downside3.01%
GradeUndervalued
TypeBlend
Dividend Yield3.13%

Risk Assessment

Beta0.12
Volatility27.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.